CN Stock MarketDetailed Quotes
600750 Jiangzhong Pharmaceutical
- 21.02
- -0.36-1.68%
Market Closed Dec 13 15:00 CST
13.22BMarket Cap17.62P/E (TTM)
21.40High20.98Low80.52KlotVolume21.31Open21.38Pre Close170.53MTurnover1.28%Turnover Ratio18.67P/E (Static)629.13MShares27.3852wk High3.56P/B13.18BFloat Cap17.6752wk Low23.52Limit Up627.15MShs Float27.38Historical High19.24Limit Down1.96%Amplitude-5.44Historical Low1.80Dividend TTM21.18Avg Price34.73KlotAsk8.56%Div YieldTTM100Lot Size43.56KlotBid
Jiangzhong Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -12.41%2.89B | -13.41%2.16B | -28.26%882.56M | 12.25%4.73B | 20.87%3.3B | 28.55%2.5B | 67.94%1.23B | 26.62%4.21B | 41.02%2.73B | 53.46%1.94B |
| Refunds of taxes and levies | -95.94%956.59K | -99.99%2.08K | -99.99%2.08K | 382.50%24.16M | 387.21%23.59M | 31,087.72%21.68M | --21.57M | --5.01M | --4.84M | --69.5K |
| Cash received relating to other operating activities | 49.42%127.68M | 59.42%114.88M | 71.49%68.72M | -56.88%39.25M | 13.91%85.45M | 42.73%72.06M | 108.60%40.07M | 35.34%91.03M | 0.77%75.01M | 8.58%50.49M |
| Cash inflows from operating activities | -11.44%3.02B | -12.11%2.28B | -26.36%951.29M | 11.22%4.79B | 21.31%3.41B | 29.99%2.59B | 71.84%1.29B | 26.95%4.31B | 39.78%2.81B | 51.87%1.99B |
| Goods services cash paid | -18.79%656.01M | -22.42%443.68M | -41.81%191.88M | 26.02%1.13B | 33.90%807.78M | 57.26%571.92M | 97.61%329.77M | 33.64%895.25M | 36.47%603.28M | 28.89%363.67M |
| Staff behalf paid | 7.01%525.76M | 5.16%384.29M | 6.67%242.77M | 8.54%658.53M | 12.54%491.31M | 15.36%365.45M | 18.94%227.58M | 15.36%606.7M | 23.51%436.57M | 23.39%316.78M |
| All taxes paid | 0.74%404.69M | -1.07%292.02M | -10.02%144.07M | 17.61%501.94M | 25.01%401.73M | 58.62%295.19M | 113.55%160.12M | 8.83%426.79M | 5.72%321.36M | 2.61%186.09M |
| Cash paid relating to other operating activities | -12.75%991.49M | -16.69%680.34M | -41.99%289.98M | 8.05%1.47B | 14.14%1.14B | 26.23%816.65M | 47.83%499.89M | 52.78%1.36B | 121.35%995.62M | 118.40%646.94M |
| Cash outflows from operating activities | -9.14%2.58B | -12.14%1.8B | -28.64%868.7M | 14.28%3.76B | 20.38%2.84B | 35.40%2.05B | 57.82%1.22B | 32.70%3.29B | 52.12%2.36B | 48.90%1.51B |
| Net cash flows from operating activities | -22.79%442.96M | -11.99%475.9M | 10.81%82.59M | 1.39%1.04B | 26.12%573.74M | 12.91%540.72M | 481.02%74.53M | 11.42%1.02B | -1.60%454.92M | 62.11%478.89M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -41.09%940.15M | -45.96%675M | -56.52%330M | -48.22%1.88B | -34.62%1.6B | -26.11%1.25B | -11.23%759M | -6.62%3.63B | -18.97%2.44B | 5.45%1.69B |
| Cash received from returns on investments | 85.61%70.16M | 190.82%41.52M | 280.56%18.19M | -22.58%41.92M | -10.89%37.8M | -51.30%14.28M | -48.85%4.78M | -11.21%54.15M | -5.75%42.42M | 17.65%29.32M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 535.25%157.41K | 747.87%113.84K | -12.17%11.79K | 360.30%245.97K | 149.70%24.78K | 45.44%13.43K | -15.39%13.43K | -95.71%53.44K | -71.34%9.92K | -63.50%9.23K |
| Cash received relating to other investing activities | ---- | ---- | ---- | ---- | --3.26M | ---- | ---- | -96.72%6.5M | ---- | ---- |
| Cash inflows from investing activities | -38.28%1.01B | -43.27%716.63M | -54.41%348.2M | -47.93%1.92B | -34.09%1.64B | -26.54%1.26B | -11.64%763.79M | -11.01%3.69B | -18.78%2.48B | 5.63%1.72B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -3.35%148.08M | -6.11%90.22M | -5.02%55.46M | -39.58%208.88M | -31.30%153.22M | -24.89%96.09M | 21.73%58.39M | 83.42%345.73M | 130.01%223.03M | 186.87%127.94M |
| Cash paid to acquire investments | -52.92%941M | -56.91%484.68M | -56.36%360M | -43.55%1.84B | -3.04%2B | -16.30%1.12B | 30.52%824.86M | -37.26%3.26B | -44.52%2.06B | -41.82%1.34B |
| Net cash paid to acquire subsidiaries and other business units | --1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | --9.82M | --12.62M | --17.17M | ---- | ---- |
| Cash outflows from investing activities | -49.35%1.09B | -53.29%574.9M | -53.63%415.46M | -43.44%2.05B | -5.80%2.15B | -16.38%1.23B | 31.75%895.88M | -32.72%3.62B | -40.08%2.28B | -37.49%1.47B |
| Net cash flows from investing activities | 84.54%-79.61M | 335.91%141.73M | 49.08%-67.26M | -285.00%-127.03M | -358.30%-514.88M | -86.88%32.51M | -171.63%-132.08M | 105.55%68.67M | 126.43%199.34M | 134.09%247.74M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -76.59%8.89M | --3.89M | --3.89M |
| Cash from borrowing | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --30M | ---- | ---- |
| Cash inflows from financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 2.44%38.89M | 67.61%3.89M | --3.89M |
| Borrowing repayment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --30M | ---- | ---- |
| Dividend interest payment | 5.66%446.19M | 8.88%445.49M | ---- | 9.19%800.5M | 0.99%422.29M | -0.33%409.14M | ---- | 133.94%733.1M | 137.56%418.17M | 133.20%410.49M |
| Cash payments relating to other financing activities | -18.41%1.89M | -10.13%1.7M | --550.74K | 268.88%16.55M | -11.30%2.32M | -27.79%1.89M | ---- | -93.94%4.49M | -96.54%2.62M | -96.54%2.62M |
| Cash outflows from financing activities | 5.53%448.09M | 8.80%447.18M | --550.74K | 6.44%817.05M | 0.91%424.61M | -0.50%411.03M | ---- | 98.12%767.58M | 67.23%420.79M | 64.17%413.11M |
| Net cash flows from financing activities | -5.53%-448.09M | -8.80%-447.18M | ---550.74K | -12.12%-817.05M | -1.85%-424.61M | -0.44%-411.03M | ---- | -108.51%-728.7M | -67.22%-416.9M | -62.63%-409.22M |
| Net cash flow | ||||||||||
| Net increase in cash and cash equivalents | 76.83%-84.74M | 5.08%170.45M | 125.67%14.77M | -74.62%91.82M | -254.09%-365.76M | -48.89%162.21M | -134.98%-57.56M | 154.07%361.72M | 143.86%237.36M | 146.48%317.4M |
| Add:Begin period cash and cash equivalents | 16.68%642.14M | 16.68%642.14M | 16.68%642.14M | 191.78%550.32M | 191.78%550.32M | 191.78%550.32M | 191.78%550.32M | -78.01%188.61M | -78.01%188.61M | -78.01%188.61M |
| End period cash equivalent | 202.01%557.41M | 14.04%812.59M | 33.31%656.91M | 16.68%642.14M | -56.67%184.57M | 40.81%712.53M | 39.53%492.77M | 191.78%550.32M | 34.59%425.97M | 189.57%506.01M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
